Please try another search
For the nine months ended 31 December 2015, Biosensors International Group Ltd revenues decreased 18% to $190.7M. Net income decreased 45% to $12.3M. Revenues reflect Interventional Cardiology segment decrease of 16% to $155.9M, Licensing Revenue segment decrease of 48% to $11.3M. Net income also reflects restructuring of operations increase from $2M to $4.2M (expense), Foreign exchange gain/(loss).
Period Ending: | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|
Total Revenue | 63.65 | 60.01 | 67.03 | 75.93 |
Gross Profit | 44.8 | 42.25 | 51.03 | 55.21 |
Operating Income | 2.92 | 0.98 | 12.89 | -260.3 |
Net Income | -1.14 | 4.01 | 9.46 | -247.04 |
Period Ending: | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|
Total Assets | 1325.19 | 1363.69 | 1410.81 | 1395.68 |
Total Liabilities | 341.32 | 364.71 | 381.29 | 381.26 |
Total Equity | 983.86 | 998.99 | 1029.53 | 1014.43 |
Period Ending: | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | 37.21 | 29.56 | 17.29 | 66.53 |
Cash From Investing Activities | -18.31 | -7.75 | -3.46 | -52.57 |
Cash From Financing Activities | 2.53 | 0.27 | -0.08 | 13.96 |
Net Change in Cash | 1.8 | 5.43 | 18.22 | 6.46 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review